Our data demonstrate that combinatorial immunotherapy consisting of adenovirus-encoded TRAIL+CpG1826 in an orthotopic RCC model in mice was effective in inducing a systemic T cell response that contributed to reducing local and metastatic tumors. This evidence concerns the gene TNFSF10 and renal cell carcinoma.